Hope Springs Eternal in Biopharma IPO Pricing but Bad Haircuts Continue
This article was originally published in Start Up
Executive Summary
While START-UP first noted an industry-wide tendency to overestimate the prices IPO investors were willing to pay in early 2005, IPOs have regularly fallen short of the anticipated price ever since, with few exceptions.